Glucagonlike peptide 1 analogs in diabetes care

Can Fam Physician. 2017 May;63(5):371.

Authors

Adrienne J Lindblad¹, Scott Garrison², G Michael Allan³

Affiliations

¹ Knowledge Translation and Evidence Coordinator with the Alberta College of Family Physicians in Edmonton.
² Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
³ Professor and Director of Evidence-Based Medicine in the Department of Family Medicine at the University of Alberta in Edmonton.

PMID: 28500195
PMCID: PMC5429054

No abstract available

MeSH terms

Cardiovascular Diseases / epidemiology
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Glucagon-Like Peptide 1 / analogs & derivatives*
Glucagon-Like Peptides / administration & dosage*
Glycated Hemoglobin / analysis
Humans
Liraglutide / administration & dosage*
Neoplasms / epidemiology
Randomized Controlled Trials as Topic

Substances

Glycated Hemoglobin A
semaglutide
Glucagon-Like Peptides
Liraglutide
Glucagon-Like Peptide 1